- Home
- NMTC vs PDSB Comparison
NMTC vs PDSB Comparison
Compare NMTC & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- PDSB
- Stock Information
- Founded
- NMTC 2009
- PDSB 2005
- Country
- NMTC United States
- PDSB United States
- Employees
- NMTC N/A
- PDSB N/A
- Industry
- NMTC Medical/Dental Instruments
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- NMTC Health Care
- PDSB Health Care
- Exchange
- NMTC Nasdaq
- PDSB Nasdaq
- Market Cap
- NMTC 45.0M
- PDSB 44.5M
- IPO Year
- NMTC N/A
- PDSB N/A
- Fundamental
- Price
- NMTC $0.82
- PDSB $0.93
- Analyst Decision
- NMTC Strong Buy
- PDSB Strong Buy
- Analyst Count
- NMTC 2
- PDSB 2
- Target Price
- NMTC $2.23
- PDSB $10.00
- AVG Volume (30 Days)
- NMTC 497.1K
- PDSB 480.1K
- Earning Date
- NMTC 12-16-2025
- PDSB 11-13-2025
- Dividend Yield
- NMTC N/A
- PDSB N/A
- EPS Growth
- NMTC N/A
- PDSB N/A
- EPS
- NMTC N/A
- PDSB N/A
- Revenue
- NMTC $6,629,051.00
- PDSB N/A
- Revenue This Year
- NMTC $162.84
- PDSB N/A
- Revenue Next Year
- NMTC $26.51
- PDSB N/A
- P/E Ratio
- NMTC N/A
- PDSB N/A
- Revenue Growth
- NMTC 69.00
- PDSB N/A
- 52 Week Low
- NMTC $0.40
- PDSB $0.85
- 52 Week High
- NMTC $1.39
- PDSB $3.48
- Technical
- Relative Strength Index (RSI)
- NMTC 43.03
- PDSB 39.80
- Support Level
- NMTC $0.76
- PDSB $0.89
- Resistance Level
- NMTC $0.89
- PDSB $0.95
- Average True Range (ATR)
- NMTC 0.06
- PDSB 0.06
- MACD
- NMTC -0.01
- PDSB 0.00
- Stochastic Oscillator
- NMTC 17.23
- PDSB 30.50
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.